Trial intelligence / Profile preview

Botox vs Radiofrequency for Vaginismus

NCT06755099Phase 3Not yet recruiting

Sponsor
Assiut University
Start
Jan 2025
Primary completion
Aug 2026
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of botulinum toxin type A in vaginismus, sponsored by Assiut University. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

botulinum toxin type A
03

Conditions

vaginismus

Beyond the preview

Go deeper on NCT06755099.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06755099.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call